The agency also proposed the manufacturers include a checklist to guide patients’ talks with their surgeons about the risks and benefits of implants. A checklist also gives patients the opportunity to ask doctors about their experience, education, training and credentials, the FDA said. The new recommendations are “designed to help inform conversations between patients and health care professionals when breast implants are being considered,” they added. About 75 percent of women who get breast implants do so for cosmetic reasons. Most of the rest get implants as part of reconstruction after surgery for breast cancer.

Source: Washington Post October 23, 2019 13:30 UTC